Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.09040049 |
2 | neutrophil activation involved in immune response (GO:0002283) | 5.66904057 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.54813247 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.54813247 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.54813247 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.54813247 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.54813247 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.54813247 |
9 | response to peptidoglycan (GO:0032494) | 5.15923976 |
10 | respiratory burst (GO:0045730) | 4.80912382 |
11 | detection of other organism (GO:0098543) | 4.70173728 |
12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.63632378 |
13 | macrophage activation involved in immune response (GO:0002281) | 4.62353177 |
14 | detection of bacterium (GO:0016045) | 4.55453562 |
15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.37299755 |
16 | positive regulation of interferon-alpha production (GO:0032727) | 4.23155500 |
17 | * immunoglobulin mediated immune response (GO:0016064) | 4.04818593 |
18 | response to muramyl dipeptide (GO:0032495) | 4.02379258 |
19 | regulation of interferon-alpha production (GO:0032647) | 3.99917447 |
20 | detection of external biotic stimulus (GO:0098581) | 3.96725871 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95517135 |
22 | leukocyte aggregation (GO:0070486) | 3.87098590 |
23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.85474434 |
24 | response to host immune response (GO:0052572) | 3.85474434 |
25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.85127094 |
26 | * granulocyte activation (GO:0036230) | 3.83610057 |
27 | * neutrophil activation (GO:0042119) | 3.81618755 |
28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.80722032 |
29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.80722032 |
30 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.78516255 |
31 | myeloid cell activation involved in immune response (GO:0002275) | 3.72896094 |
32 | positive regulation of B cell differentiation (GO:0045579) | 3.70391930 |
33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.63388435 |
34 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.61258995 |
35 | natural killer cell mediated immunity (GO:0002228) | 3.61258995 |
36 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.59008370 |
37 | positive regulation of mast cell degranulation (GO:0043306) | 3.59008370 |
38 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.56776295 |
39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.55729824 |
40 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.54701756 |
41 | positive regulation of mast cell activation (GO:0033005) | 3.52059085 |
42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.51357114 |
43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51178761 |
44 | neutrophil mediated immunity (GO:0002446) | 3.51166911 |
45 | reactive oxygen species biosynthetic process (GO:1903409) | 3.50886278 |
46 | detection of biotic stimulus (GO:0009595) | 3.48533021 |
47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.47179501 |
48 | response to host (GO:0075136) | 3.47179501 |
49 | response to host defenses (GO:0052200) | 3.47179501 |
50 | cellular extravasation (GO:0045123) | 3.45890300 |
51 | regulation of mast cell degranulation (GO:0043304) | 3.44472430 |
52 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42807426 |
53 | negative regulation of interleukin-12 production (GO:0032695) | 3.40140890 |
54 | superoxide anion generation (GO:0042554) | 3.39655159 |
55 | leukocyte mediated cytotoxicity (GO:0001909) | 3.37556353 |
56 | defense response to protozoan (GO:0042832) | 3.37348956 |
57 | cellular response to zinc ion (GO:0071294) | 3.37028637 |
58 | response to type I interferon (GO:0034340) | 3.36305913 |
59 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35297235 |
60 | cellular response to type I interferon (GO:0071357) | 3.34950024 |
61 | type I interferon signaling pathway (GO:0060337) | 3.34950024 |
62 | regulation of B cell differentiation (GO:0045577) | 3.34800977 |
63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32398596 |
64 | microglial cell activation (GO:0001774) | 3.31561978 |
65 | positive regulation of interferon-beta production (GO:0032728) | 3.27567300 |
66 | macrophage activation (GO:0042116) | 3.23368551 |
67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.21772686 |
68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21145525 |
69 | NIK/NF-kappaB signaling (GO:0038061) | 3.19780190 |
70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19618646 |
71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19436473 |
72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.18328404 |
73 | regulation of mast cell activation (GO:0033003) | 3.18123257 |
74 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.17539375 |
75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.16052395 |
76 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.14864823 |
77 | negative regulation of interleukin-17 production (GO:0032700) | 3.08260513 |
78 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07287806 |
79 | B cell receptor signaling pathway (GO:0050853) | 3.06761198 |
80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05466898 |
81 | positive regulation of leukocyte degranulation (GO:0043302) | 3.05360111 |
82 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.02535069 |
83 | response to protozoan (GO:0001562) | 3.02283728 |
84 | leukocyte cell-cell adhesion (GO:0007159) | 3.01185852 |
85 | regulation of tolerance induction (GO:0002643) | 3.01016301 |
86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96736675 |
87 | negative regulation of cell killing (GO:0031342) | 2.96736675 |
88 | regulation of antigen processing and presentation (GO:0002577) | 2.96657746 |
89 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.95663270 |
90 | regulation of T cell tolerance induction (GO:0002664) | 2.95609724 |
91 | regulation of leukocyte degranulation (GO:0043300) | 2.95376329 |
92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95144096 |
93 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94505046 |
94 | myeloid dendritic cell activation (GO:0001773) | 2.93334156 |
95 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.91460341 |
96 | positive regulation of type 2 immune response (GO:0002830) | 2.91381995 |
97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.91282612 |
98 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89276697 |
99 | myeloid dendritic cell differentiation (GO:0043011) | 2.89219133 |
100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.88747118 |
101 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88508151 |
102 | neutrophil chemotaxis (GO:0030593) | 2.88409933 |
103 | * B cell mediated immunity (GO:0019724) | 2.85772444 |
104 | * myeloid leukocyte activation (GO:0002274) | 2.82539512 |
105 | negative regulation of innate immune response (GO:0045824) | 2.82027016 |
106 | detection of molecule of bacterial origin (GO:0032490) | 2.81944664 |
107 | neutrophil migration (GO:1990266) | 2.81269734 |
108 | response to interleukin-15 (GO:0070672) | 2.80947491 |
109 | response to interferon-alpha (GO:0035455) | 2.80834252 |
110 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.79321086 |
111 | leukocyte degranulation (GO:0043299) | 2.78862739 |
112 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78718504 |
113 | I-kappaB phosphorylation (GO:0007252) | 2.77333039 |
114 | myeloid leukocyte mediated immunity (GO:0002444) | 2.76765527 |
115 | regulation of regulated secretory pathway (GO:1903305) | 2.76541419 |
116 | negative regulation of interleukin-6 production (GO:0032715) | 2.76000192 |
117 | regulation of chemokine biosynthetic process (GO:0045073) | 2.75523315 |
118 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.75479677 |
119 | tolerance induction (GO:0002507) | 2.75470237 |
120 | cytokine secretion (GO:0050663) | 2.73837169 |
121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.73686066 |
122 | germinal center formation (GO:0002467) | 2.72435170 |
123 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.72313304 |
124 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71196887 |
125 | response to fungus (GO:0009620) | 2.71104347 |
126 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.71063736 |
127 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.69740325 |
128 | T-helper 1 type immune response (GO:0042088) | 2.68859756 |
129 | regulation of type 2 immune response (GO:0002828) | 2.67513457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.93762939 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.86242063 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.09892222 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.08294730 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.87897412 |
6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64159693 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61166664 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58382257 |
9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.36531750 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26078661 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.20847856 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.20793801 |
13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.12984113 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.01870312 |
15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.78519511 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66672552 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.47889053 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40006526 |
19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.38214648 |
20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.37875381 |
21 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.36874398 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.33180277 |
23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.30116936 |
24 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.16913290 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13378979 |
26 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.10188939 |
27 | MYB_26560356_Chip-Seq_TH2_Human | 2.02009924 |
28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00039416 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98915652 |
30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.95850633 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94668110 |
32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.91402601 |
33 | * MAF_26560356_Chip-Seq_TH1_Human | 1.88675823 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85431971 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82478202 |
36 | MYB_26560356_Chip-Seq_TH1_Human | 1.71329186 |
37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71316417 |
38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.68788261 |
39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64664310 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60991570 |
41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60817341 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58824035 |
43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57904500 |
44 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50006493 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49526507 |
46 | MYC_22102868_ChIP-Seq_BL_Human | 1.49473356 |
47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48169876 |
48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47574516 |
49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45413615 |
50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44223227 |
51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42724511 |
52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41763006 |
53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36744227 |
54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34973905 |
55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34051097 |
56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33304705 |
57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30230617 |
58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29231239 |
59 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27785524 |
60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27643834 |
61 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25733122 |
62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25037263 |
63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24889682 |
64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24022145 |
65 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23476937 |
66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19281095 |
67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18229609 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17805321 |
69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17425948 |
70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15988355 |
71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15118116 |
72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12153987 |
73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09222284 |
74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08760652 |
75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07953766 |
76 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.07278779 |
77 | MAF_26560356_Chip-Seq_TH2_Human | 1.06813866 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06613768 |
79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06599738 |
80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04302566 |
81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03955483 |
82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02940446 |
83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01120553 |
84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00536653 |
85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99027546 |
86 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98203940 |
87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97619953 |
88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97613808 |
89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97532331 |
90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96816353 |
91 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93322189 |
92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92516459 |
93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90527285 |
94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90345092 |
95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90341528 |
96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90139343 |
97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89352879 |
98 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88237634 |
99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87693172 |
100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86136308 |
101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83141439 |
102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82394539 |
103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82193867 |
104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82193867 |
105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81019520 |
106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78917822 |
107 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76923372 |
108 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76411089 |
109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74771003 |
110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74016363 |
111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73351837 |
112 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73073917 |
113 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69918322 |
114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68801371 |
115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.68664485 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.50607862 |
2 | MP0003436_decreased_susceptibility_to | 3.76741267 |
3 | MP0003303_peritoneal_inflammation | 3.44515207 |
4 | MP0009785_altered_susceptibility_to | 3.35778688 |
5 | MP0002148_abnormal_hypersensitivity_rea | 3.17840667 |
6 | * MP0002419_abnormal_innate_immunity | 3.12917000 |
7 | * MP0005000_abnormal_immune_tolerance | 3.00478867 |
8 | MP0005025_abnormal_response_to | 2.88135799 |
9 | MP0000685_abnormal_immune_system | 2.81622268 |
10 | MP0001790_abnormal_immune_system | 2.78947306 |
11 | MP0005387_immune_system_phenotype | 2.78947306 |
12 | * MP0002452_abnormal_antigen_presenting | 2.76827488 |
13 | MP0005058_abnormal_lysosome_morphology | 2.73030022 |
14 | * MP0001800_abnormal_humoral_immune | 2.69318820 |
15 | MP0006082_CNS_inflammation | 2.56055432 |
16 | * MP0002723_abnormal_immune_serum | 2.51883665 |
17 | MP0005464_abnormal_platelet_physiology | 2.42131535 |
18 | MP0003724_increased_susceptibility_to | 2.40883214 |
19 | * MP0001819_abnormal_immune_cell | 2.36802552 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.35438121 |
21 | * MP0005671_abnormal_response_to | 2.24470169 |
22 | MP0009278_abnormal_bone_marrow | 2.24244396 |
23 | MP0004510_myositis | 2.22908375 |
24 | MP0004947_skin_inflammation | 2.12433789 |
25 | MP0003172_abnormal_lysosome_physiology | 2.09751309 |
26 | MP0000569_abnormal_digit_pigmentation | 2.09273201 |
27 | MP0002405_respiratory_system_inflammati | 2.04248763 |
28 | MP0005451_abnormal_body_composition | 1.98158001 |
29 | MP0001533_abnormal_skeleton_physiology | 1.94156542 |
30 | MP0001853_heart_inflammation | 1.88553594 |
31 | * MP0001845_abnormal_inflammatory_respons | 1.88408094 |
32 | MP0010155_abnormal_intestine_physiology | 1.87347864 |
33 | MP0002006_tumorigenesis | 1.83528345 |
34 | MP0005397_hematopoietic_system_phenotyp | 1.78861737 |
35 | MP0001545_abnormal_hematopoietic_system | 1.78861737 |
36 | * MP0000716_abnormal_immune_system | 1.76883500 |
37 | * MP0002398_abnormal_bone_marrow | 1.75085795 |
38 | MP0002166_altered_tumor_susceptibility | 1.66732135 |
39 | MP0003300_gastrointestinal_ulcer | 1.63908677 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.57184933 |
41 | MP0003183_abnormal_peptide_metabolism | 1.56571447 |
42 | MP0005310_abnormal_salivary_gland | 1.54836839 |
43 | MP0009764_decreased_sensitivity_to | 1.53576147 |
44 | MP0003448_altered_tumor_morphology | 1.52987234 |
45 | MP0005174_abnormal_tail_pigmentation | 1.52178826 |
46 | MP0008469_abnormal_protein_level | 1.50305453 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.49028019 |
48 | MP0000343_altered_response_to | 1.48839634 |
49 | * MP0000689_abnormal_spleen_morphology | 1.47331060 |
50 | MP0000858_altered_metastatic_potential | 1.46774210 |
51 | MP0002132_abnormal_respiratory_system | 1.46326445 |
52 | * MP0002429_abnormal_blood_cell | 1.45949724 |
53 | * MP0002722_abnormal_immune_system | 1.37203203 |
54 | MP0002396_abnormal_hematopoietic_system | 1.33253111 |
55 | MP0001873_stomach_inflammation | 1.30018894 |
56 | MP0002998_abnormal_bone_remodeling | 1.29637758 |
57 | MP0004808_abnormal_hematopoietic_stem | 1.26122652 |
58 | MP0008004_abnormal_stomach_pH | 1.24136402 |
59 | MP0000465_gastrointestinal_hemorrhage | 1.20347922 |
60 | MP0003566_abnormal_cell_adhesion | 1.19265265 |
61 | MP0005167_abnormal_blood-brain_barrier | 1.18549018 |
62 | MP0010307_abnormal_tumor_latency | 1.18208755 |
63 | MP0009840_abnormal_foam_cell | 1.17821118 |
64 | MP0005166_decreased_susceptibility_to | 1.16780757 |
65 | MP0003866_abnormal_defecation | 1.14553794 |
66 | MP0005076_abnormal_cell_differentiation | 1.14437603 |
67 | MP0004883_abnormal_blood_vessel | 1.12649631 |
68 | * MP0003075_altered_response_to | 1.12035655 |
69 | MP0000490_abnormal_crypts_of | 1.11641532 |
70 | MP0010352_gastrointestinal_tract_polyps | 1.07755268 |
71 | MP0001851_eye_inflammation | 1.06222100 |
72 | MP0004381_abnormal_hair_follicle | 1.03543115 |
73 | MP0003828_pulmonary_edema | 1.02983253 |
74 | MP0003763_abnormal_thymus_physiology | 0.96948651 |
75 | MP0002254_reproductive_system_inflammat | 0.96293785 |
76 | MP0003453_abnormal_keratinocyte_physiol | 0.92505075 |
77 | MP0000604_amyloidosis | 0.91475840 |
78 | MP0002277_abnormal_respiratory_mucosa | 0.91046450 |
79 | MP0003806_abnormal_nucleotide_metabolis | 0.91011911 |
80 | MP0005390_skeleton_phenotype | 0.90010887 |
81 | MP0008260_abnormal_autophagy | 0.89887597 |
82 | MP0000371_diluted_coat_color | 0.89587135 |
83 | MP0002933_joint_inflammation | 0.89509898 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 0.88996041 |
85 | MP0000015_abnormal_ear_pigmentation | 0.87778531 |
86 | MP0004185_abnormal_adipocyte_glucose | 0.79490897 |
87 | MP0009763_increased_sensitivity_to | 0.78672718 |
88 | MP0005666_abnormal_adipose_tissue | 0.77710051 |
89 | MP0000703_abnormal_thymus_morphology | 0.77288639 |
90 | MP0005164_abnormal_response_to | 0.77117611 |
91 | MP0000249_abnormal_blood_vessel | 0.74837240 |
92 | MP0001958_emphysema | 0.74667724 |
93 | MP0003705_abnormal_hypodermis_morpholog | 0.72183040 |
94 | MP0008874_decreased_physiological_sensi | 0.70574363 |
95 | * MP0002136_abnormal_kidney_physiology | 0.69948559 |
96 | MP0001663_abnormal_digestive_system | 0.69342695 |
97 | MP0003091_abnormal_cell_migration | 0.69117340 |
98 | MP0005023_abnormal_wound_healing | 0.67539760 |
99 | MP0009765_abnormal_xenobiotic_induced | 0.66400361 |
100 | MP0003045_fibrosis | 0.66246454 |
101 | MP0003690_abnormal_glial_cell | 0.64856601 |
102 | MP0000609_abnormal_liver_physiology | 0.63368978 |
103 | MP0002019_abnormal_tumor_incidence | 0.63287032 |
104 | * MP0003795_abnormal_bone_structure | 0.63112604 |
105 | MP0010234_abnormal_vibrissa_follicle | 0.63021425 |
106 | MP0004782_abnormal_surfactant_physiolog | 0.62030158 |
107 | MP0004858_abnormal_nervous_system | 0.60669931 |
108 | MP0009115_abnormal_fat_cell | 0.60244005 |
109 | MP0005319_abnormal_enzyme/_coenzyme | 0.59608674 |
110 | MP0002877_abnormal_melanocyte_morpholog | 0.59549271 |
111 | MP0002139_abnormal_hepatobiliary_system | 0.56420802 |
112 | MP0001216_abnormal_epidermal_layer | 0.56365490 |
113 | MP0001986_abnormal_taste_sensitivity | 0.53796699 |
114 | MP0003186_abnormal_redox_activity | 0.52854210 |
115 | MP0002138_abnormal_hepatobiliary_system | 0.52506606 |
116 | MP0001191_abnormal_skin_condition | 0.52275039 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.47499135 |
2 | Eczematoid dermatitis (HP:0000976) | 6.98201056 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.87640776 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.65004214 |
5 | Abnormality of macrophages (HP:0004311) | 4.96839429 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 4.78927800 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31258293 |
8 | Recurrent skin infections (HP:0001581) | 4.26981502 |
9 | Myositis (HP:0100614) | 4.26056426 |
10 | Recurrent fungal infections (HP:0002841) | 4.20813518 |
11 | Gingivitis (HP:0000230) | 4.11133529 |
12 | Vacuolated lymphocytes (HP:0001922) | 4.03152822 |
13 | Increased cerebral lipofuscin (HP:0011813) | 3.93877915 |
14 | Cellulitis (HP:0100658) | 3.92168256 |
15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.86773423 |
16 | Obstructive lung disease (HP:0006536) | 3.86773423 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 3.80439987 |
18 | Recurrent viral infections (HP:0004429) | 3.70861486 |
19 | Orchitis (HP:0100796) | 3.57686019 |
20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.50846684 |
21 | Pustule (HP:0200039) | 3.47573994 |
22 | Periodontitis (HP:0000704) | 3.33071083 |
23 | Retrobulbar optic neuritis (HP:0100654) | 3.30841016 |
24 | Optic neuritis (HP:0100653) | 3.30841016 |
25 | Systemic lupus erythematosus (HP:0002725) | 3.29917006 |
26 | Stomatitis (HP:0010280) | 3.25588130 |
27 | Interstitial pulmonary disease (HP:0006530) | 3.21983725 |
28 | Meningitis (HP:0001287) | 3.18647618 |
29 | Encephalitis (HP:0002383) | 3.12225074 |
30 | * Vasculitis (HP:0002633) | 3.06954689 |
31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.05529697 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.05529697 |
33 | Purpura (HP:0000979) | 3.00726765 |
34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98297895 |
35 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98297895 |
36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98297895 |
37 | Osteomyelitis (HP:0002754) | 2.98267715 |
38 | Disinhibition (HP:0000734) | 2.93443612 |
39 | Amyloidosis (HP:0011034) | 2.92395742 |
40 | Chronic otitis media (HP:0000389) | 2.90518304 |
41 | Hematochezia (HP:0002573) | 2.90169221 |
42 | Colitis (HP:0002583) | 2.87447061 |
43 | Axonal loss (HP:0003447) | 2.81675223 |
44 | Prostate neoplasm (HP:0100787) | 2.78132923 |
45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.76067141 |
46 | Urticaria (HP:0001025) | 2.74991872 |
47 | Recurrent pneumonia (HP:0006532) | 2.69838856 |
48 | Inflammation of the large intestine (HP:0002037) | 2.67235026 |
49 | Dysostosis multiplex (HP:0000943) | 2.65688265 |
50 | Pulmonary infiltrates (HP:0002113) | 2.61132739 |
51 | Basal ganglia calcification (HP:0002135) | 2.59666970 |
52 | Thick nail (HP:0001805) | 2.56261437 |
53 | Leukocytosis (HP:0001974) | 2.55097710 |
54 | Gastrointestinal inflammation (HP:0004386) | 2.53975857 |
55 | Petechiae (HP:0000967) | 2.48408713 |
56 | Agammaglobulinemia (HP:0004432) | 2.48362822 |
57 | Episodic fever (HP:0001954) | 2.46706601 |
58 | IgM deficiency (HP:0002850) | 2.44000856 |
59 | Recurrent bronchitis (HP:0002837) | 2.41047026 |
60 | Arterial thrombosis (HP:0004420) | 2.40440846 |
61 | Recurrent lower respiratory tract infections (HP:0002783) | 2.40001738 |
62 | Sepsis (HP:0100806) | 2.37603551 |
63 | Thrombocytosis (HP:0001894) | 2.35194953 |
64 | Increased serum ferritin (HP:0003281) | 2.35156833 |
65 | Anorexia (HP:0002039) | 2.34836810 |
66 | Increased IgE level (HP:0003212) | 2.31668694 |
67 | Pulmonary embolism (HP:0002204) | 2.28912043 |
68 | Nasal polyposis (HP:0100582) | 2.28846683 |
69 | Spontaneous hematomas (HP:0007420) | 2.28196041 |
70 | Premature loss of primary teeth (HP:0006323) | 2.27573008 |
71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27313838 |
72 | Mucopolysacchariduria (HP:0008155) | 2.27313838 |
73 | Agnosia (HP:0010524) | 2.24260024 |
74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23512513 |
75 | Osteolytic defects of the hand bones (HP:0009699) | 2.23512513 |
76 | Hemoptysis (HP:0002105) | 2.22993936 |
77 | Skin ulcer (HP:0200042) | 2.20984813 |
78 | Tetraparesis (HP:0002273) | 2.20190526 |
79 | Malnutrition (HP:0004395) | 2.19448540 |
80 | Gingival bleeding (HP:0000225) | 2.19229855 |
81 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19164024 |
82 | Gangrene (HP:0100758) | 2.18805759 |
83 | Prolonged bleeding time (HP:0003010) | 2.17659000 |
84 | T lymphocytopenia (HP:0005403) | 2.17147705 |
85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16817474 |
86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16817474 |
87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16817474 |
88 | Hypergammaglobulinemia (HP:0010702) | 2.16359383 |
89 | Abnormality of the nasal mucosa (HP:0000433) | 2.15261459 |
90 | Loss of speech (HP:0002371) | 2.14671112 |
91 | Hypochromic anemia (HP:0001931) | 2.12796764 |
92 | Myocardial infarction (HP:0001658) | 2.12306102 |
93 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.11905845 |
94 | Abnormal platelet volume (HP:0011876) | 2.08651855 |
95 | Abnormality of T cell number (HP:0011839) | 2.06691495 |
96 | Eosinophilia (HP:0001880) | 2.06366217 |
97 | Abnormality of the pleura (HP:0002103) | 2.05119776 |
98 | Abnormality of iron homeostasis (HP:0011031) | 2.05056323 |
99 | Epistaxis (HP:0000421) | 2.04917970 |
100 | Cheilitis (HP:0100825) | 2.02421930 |
101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01864961 |
102 | Albinism (HP:0001022) | 1.99163558 |
103 | Glomerulopathy (HP:0100820) | 1.98759439 |
104 | Abnormality of the prostate (HP:0008775) | 1.98514379 |
105 | Abnormality of T cells (HP:0002843) | 1.97771024 |
106 | Increased IgM level (HP:0003496) | 1.96536575 |
107 | Peritonitis (HP:0002586) | 1.96531828 |
108 | Thyroiditis (HP:0100646) | 1.95662074 |
109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95351161 |
110 | Keratoconjunctivitis sicca (HP:0001097) | 1.93106934 |
111 | Gastrointestinal infarctions (HP:0005244) | 1.92584689 |
112 | Abnormality of the peritoneum (HP:0002585) | 1.92203675 |
113 | Hypertensive crisis (HP:0100735) | 1.91634589 |
114 | Abnormality of the endocardium (HP:0004306) | 1.90071437 |
115 | Hypochromic microcytic anemia (HP:0004840) | 1.90050654 |
116 | Chest pain (HP:0100749) | 1.89774192 |
117 | Abnormality of T cell physiology (HP:0011840) | 1.88654348 |
118 | Hepatosplenomegaly (HP:0001433) | 1.85511118 |
119 | Thoracic kyphosis (HP:0002942) | 1.83912159 |
120 | Granulocytopenia (HP:0001913) | 1.80559878 |
121 | Bone pain (HP:0002653) | 1.79105090 |
122 | Keratoconjunctivitis (HP:0001096) | 1.76564568 |
123 | Recurrent sinusitis (HP:0011108) | 1.76396220 |
124 | Panhypogammaglobulinemia (HP:0003139) | 1.76150722 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 3.91688348 |
2 | MAP3K14 | 3.81565924 |
3 | MAP4K1 | 3.39783016 |
4 | TBK1 | 3.39063032 |
5 | TYK2 | 3.09898946 |
6 | IRAK4 | 3.06228725 |
7 | PRPF4B | 2.84930777 |
8 | KIT | 2.61953852 |
9 | IRAK3 | 2.60194604 |
10 | ERN1 | 2.53299296 |
11 | JAK3 | 2.41084159 |
12 | * RIPK4 | 2.33567995 |
13 | IKBKE | 2.29105038 |
14 | IKBKB | 2.21957728 |
15 | JAK1 | 1.99588553 |
16 | TNK2 | 1.98268444 |
17 | CSF1R | 1.93420008 |
18 | MATK | 1.79422314 |
19 | STK10 | 1.72460351 |
20 | TAOK2 | 1.70922691 |
21 | BTK | 1.69902770 |
22 | TGFBR2 | 1.69629041 |
23 | ZAP70 | 1.69619813 |
24 | SYK | 1.68834771 |
25 | MAP3K13 | 1.66826026 |
26 | CSK | 1.65630906 |
27 | TAOK3 | 1.59839085 |
28 | PIM2 | 1.58625273 |
29 | TXK | 1.52942402 |
30 | MARK3 | 1.51566518 |
31 | HCK | 1.48658500 |
32 | MAP3K10 | 1.42305448 |
33 | SMG1 | 1.42121054 |
34 | MAP2K3 | 1.37515219 |
35 | CHUK | 1.33427595 |
36 | PIM1 | 1.32329302 |
37 | RPS6KA4 | 1.30264547 |
38 | PBK | 1.28064072 |
39 | EPHB1 | 1.26602480 |
40 | LRRK2 | 1.25692101 |
41 | MST4 | 1.25677116 |
42 | TEC | 1.25519648 |
43 | SIK1 | 1.17694571 |
44 | * LYN | 1.16414596 |
45 | JAK2 | 1.13873895 |
46 | TRIB3 | 1.13792458 |
47 | * LCK | 1.13412122 |
48 | CDC42BPA | 1.12805331 |
49 | MST1R | 1.12215780 |
50 | RIPK1 | 1.08606685 |
51 | TRPM7 | 1.07595858 |
52 | TESK2 | 1.05498589 |
53 | SIK2 | 1.04931385 |
54 | FES | 1.04215065 |
55 | NME2 | 1.00138165 |
56 | BMPR2 | 0.99952556 |
57 | PRKD2 | 0.97292031 |
58 | IRAK1 | 0.96015975 |
59 | CLK1 | 0.95834265 |
60 | MARK2 | 0.94284569 |
61 | IRAK2 | 0.93424062 |
62 | NEK9 | 0.89472192 |
63 | FLT3 | 0.87844468 |
64 | GRK6 | 0.86695855 |
65 | PTK6 | 0.85166333 |
66 | FGR | 0.84992708 |
67 | TESK1 | 0.84098004 |
68 | STK4 | 0.81104591 |
69 | FGFR3 | 0.80336280 |
70 | CAMK1D | 0.77524342 |
71 | BMX | 0.76349932 |
72 | MAP3K3 | 0.74569037 |
73 | * PDPK1 | 0.73406139 |
74 | MAP3K11 | 0.73165292 |
75 | ITK | 0.71847906 |
76 | * PDK1 | 0.71292896 |
77 | GRK7 | 0.70406637 |
78 | SIK3 | 0.70372157 |
79 | TTN | 0.67613630 |
80 | MAPK12 | 0.66290610 |
81 | EGFR | 0.64759158 |
82 | MAPK7 | 0.63668229 |
83 | PIK3CG | 0.62249063 |
84 | HIPK2 | 0.62239021 |
85 | EEF2K | 0.61860317 |
86 | PAK4 | 0.60070309 |
87 | MAP3K5 | 0.59939742 |
88 | PKN2 | 0.59419874 |
89 | MAP3K6 | 0.58810639 |
90 | CDK6 | 0.57350047 |
91 | PRKG2 | 0.56412188 |
92 | FGFR4 | 0.55601320 |
93 | * ABL1 | 0.54023551 |
94 | * PRKCD | 0.53991582 |
95 | MAPKAPK2 | 0.52390800 |
96 | MAP3K1 | 0.50981790 |
97 | KSR2 | 0.50858140 |
98 | MAP2K6 | 0.50786914 |
99 | STK3 | 0.49910918 |
100 | MOS | 0.49805215 |
101 | SCYL2 | 0.48549913 |
102 | DDR2 | 0.46533534 |
103 | CDK12 | 0.46295453 |
104 | NLK | 0.44330710 |
105 | ABL2 | 0.43886096 |
106 | ICK | 0.43772448 |
107 | RPS6KA6 | 0.43080473 |
108 | MAP2K2 | 0.42181508 |
109 | MAP3K8 | 0.41541630 |
110 | RET | 0.41198386 |
111 | SGK3 | 0.40775435 |
112 | MAPKAPK3 | 0.40250754 |
113 | ARAF | 0.39097761 |
114 | CAMKK1 | 0.38216069 |
115 | ADRBK2 | 0.38121995 |
116 | PTK2B | 0.36869857 |
117 | EIF2AK2 | 0.36485942 |
118 | RPS6KA2 | 0.36230392 |
119 | MAP3K7 | 0.34953766 |
120 | MAP3K2 | 0.32054269 |
121 | PRKCQ | 0.31466656 |
122 | EPHA3 | 0.30781310 |
123 | CDK4 | 0.29682312 |
124 | MAPK4 | 0.29286361 |
125 | RPS6KC1 | 0.29009892 |
126 | RPS6KL1 | 0.29009892 |
127 | NEK2 | 0.28889579 |
128 | ALK | 0.28392928 |
129 | TAOK1 | 0.27121529 |
130 | * FYN | 0.27070725 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.44277759 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63215406 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.59066374 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52000648 |
5 | Legionellosis_Homo sapiens_hsa05134 | 2.45071728 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43505814 |
7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29087837 |
8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26416288 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.24763373 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.21136678 |
11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.02898088 |
12 | Measles_Homo sapiens_hsa05162 | 2.02374381 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01585470 |
14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94695746 |
15 | Malaria_Homo sapiens_hsa05144 | 1.88993132 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83487375 |
17 | Influenza A_Homo sapiens_hsa05164 | 1.81751134 |
18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81705996 |
19 | Lysosome_Homo sapiens_hsa04142 | 1.81579767 |
20 | Salmonella infection_Homo sapiens_hsa05132 | 1.79334430 |
21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76792936 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75521336 |
23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66697660 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63929135 |
25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.62209477 |
26 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59353849 |
27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59286011 |
28 | Allograft rejection_Homo sapiens_hsa05330 | 1.58963093 |
29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.58508896 |
30 | Asthma_Homo sapiens_hsa05310 | 1.53671091 |
31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53585604 |
32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53548291 |
33 | Apoptosis_Homo sapiens_hsa04210 | 1.48980260 |
34 | Phagosome_Homo sapiens_hsa04145 | 1.48287450 |
35 | Shigellosis_Homo sapiens_hsa05131 | 1.47288135 |
36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45614298 |
37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45291557 |
38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39122647 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36580458 |
40 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32716314 |
41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26710256 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24418948 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17947995 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.16861764 |
45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14597257 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06143106 |
47 | Hepatitis C_Homo sapiens_hsa05160 | 1.05392539 |
48 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03238318 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02640417 |
50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02488742 |
51 | Amoebiasis_Homo sapiens_hsa05146 | 0.95091226 |
52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94675384 |
53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92868730 |
54 | Platelet activation_Homo sapiens_hsa04611 | 0.91994013 |
55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89687385 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88680072 |
57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87394954 |
58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84791140 |
59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82235051 |
60 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78491709 |
61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77346783 |
62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77070589 |
63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74905185 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73099778 |
65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72348889 |
66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72278131 |
67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68232195 |
68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64591642 |
69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63712467 |
70 | Mineral absorption_Homo sapiens_hsa04978 | 0.61386491 |
71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61051988 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60525775 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58954203 |
74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58492808 |
75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55403640 |
76 | Bladder cancer_Homo sapiens_hsa05219 | 0.55348413 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53666198 |
78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50832758 |
79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50040549 |
80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50024289 |
81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48536678 |
82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46247518 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45086133 |
84 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45025758 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.44945195 |
86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43354866 |
87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42795784 |
88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42348865 |
89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42099058 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42071595 |
91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40990024 |
92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40140747 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.37056019 |
94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36491928 |
95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36098924 |
96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35289512 |
97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34907052 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32427646 |
99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32363621 |
100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31654812 |
101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31166423 |
102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30875588 |
103 | * Insulin resistance_Homo sapiens_hsa04931 | 0.30073007 |
104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29804058 |
105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29296263 |
106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28989175 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28594340 |
108 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27612233 |
109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27574442 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27295340 |
111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26934735 |
112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.26310753 |
113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25458908 |
114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25168364 |
115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24943484 |
116 | Prion diseases_Homo sapiens_hsa05020 | 0.24562029 |